REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Pro Buono (Lithuania)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
Full name: UAB Pro Buono Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB Pro Buono is based in Lithuania, with the head office in Vilnius. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was first established on February 27, 2007. There are currently 9 (2025) people employed by UAB Pro Buono. The latest financial highlights indicate a net sales revenue increase of 19.18% in 2024. The net profit margin of UAB Pro Buono decreased by 0.78% in 2024.

Headquarters
Avizieniu sen. Uzubaliu k. Senasis Ukmerges kel. 4
Vilnius; Vilnius county; Postal Code: LT-14302

Contact Details: Purchase the UAB Pro Buono report to view the information.

Basic Information
Total Employees:
Purchase the UAB Pro Buono report to view the information.
Registered Capital:
Purchase the UAB Pro Buono report to view the information.
Financial Auditors:
Purchase the UAB Pro Buono report to view the information.
Incorporation Date:
February 27, 2007
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after UAB Pro Buono report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
19.18%
Total operating revenue
19.18%
Net Profit (Loss) for the Period
11.17%
Total Equity
20.15%
Net Profit Margin
-0.78%
Return on Equity (ROE)
-3.39%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?